We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Latest Whitepapers

Disease Population

The Transformative Potential of Metabolomics in Complex Chronic Disease Research

Genomics, proteomics and microbiomics are all useful tools in complex disease research. However, using these tools alone can risk critical knowledge gaps and leave researchers struggling to predict disease outcomes.

Get the Latest Clinical Insights for Tumor Exome Profiling

This whitepaper explores the latest reagents and software available to enhance tumor exome profiling for the generation of accurate, actionable clinical insights.


Quantitative Proteomics Services To Upgrade Your Research

Proteomics provides crucial insights into cell signaling and disease mechanisms for biomedical and clinical research. Nevertheless, traditional LC-MS/MS methods have limitations in sensitivity, reproducibility and scalability within proteomics applications.
Cancer Drugs

How To Accelerate and De-Risk Drug Development in Oncology

Although there are initiatives to de-risk the drug development process, continually applying the same tools and approaches is unlikely to lead to innovative, first- or best-in-class targets and transformative progress.
More Lipid Nanoparticles

Unlocking More Lipid Nanoparticle Insights

Developing mRNA-based therapeutics is complex work, requiring highly skilled scientists, high-tech microfluidics platforms and sophisticated analytical equipment, and of course the mRNA itself.
Advance Human Genomics

Advancing Human Genomics With Nanopore Sequencing

This whitepaper highlights specific case studies that reveal how researchers are applying nanopore technology to a variety of sequencing techniques, including whole genome, targeted, RNA sequencing and single-cell analysis.
Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases content piece image

Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases

The SomaScan Assay is an ideal high throughput platform for identifying proteins that may be involved in disease pathology, as it offers a highly sensitive method of quantifying proteins in different biologic fluids such as serum, plasma, urine and cerebrospinal fluid.
Investigating Cell-Free DNA in Liquid Biopsy content piece image

Investigating Cell-Free DNA in Liquid Biopsy

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.
Making the Switch to In-House Mycoplasma Testing content piece image

Making the Switch to In-House Mycoplasma Testing

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.
Human Whole Transcriptome Atlas content piece image

Human Whole Transcriptome Atlas

GeoMx® Human Whole Transcriptome Atlas

Traditional gene expression technologies are unable to capture heterogeneity of the transcriptome with spatial context.